Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HPC, Cord Blood
- Development stage
- Unknown
- Lead developer
- New York Blood Center
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
HPC, Cord Blood (New York Blood Center) consists of hematopoietic progenitor cells (HPC) derived from human umbilical cord blood, collected and processed by the National Cord Blood Program (NCBP). These cells are used in allogeneic hematopoietic stem cell transplantation (HSCT) to treat patients with various hematopoietic system diseases, including hematologic malignancies (like leukemia and lymphoma), bone marrow failure syndromes, and certain inherited metabolic or immune disorders. The therapeutic effect is achieved through the engraftment of the donor stem cells into the recipient's bone marrow, where they reconstitute the blood and immune systems. While NYBC markets a licensed version under the brand name HEMACORD, this specific entry refers to the unlicensed, investigational units used in clinical safety studies to evaluate infusion-related reactions and engraftment.
- Brand names
- HEMACORD
- Other names
- Cord Blood UnitsUmbilical Cord BloodHematopoietic Progenitor Cells, Cord BloodNCBP Cord Blood Units
Beyond the preview
Go deeper on HPC, Cord Blood.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HPC, Cord Blood.